SWK Holdings Announces Closing of Royalty Sale and $4.00 Per Share Special Dividend
SWK Holdings (NASDAQ:SWKH) has completed the previously announced sale of its royalty assets to SCOF SPV I, LP, a Soleus Capital Management affiliate, for $34.0 million in cash proceeds. Following this transaction, the company's Board has declared a special cash dividend of $4.00 per share, with a record date of April 24, 2025, and payment scheduled for May 8, 2025.
The transaction value aligns with the GAAP carrying value of the royalty assets. CEO Jody Staggs highlighted that SWK maintains a strong position with an approximately $220 million performing life science loan portfolio generating attractive cash yields.
SWK Holdings (NASDAQ:SWKH) ha completato la vendita precedentemente annunciata dei suoi asset di royalty a SCOF SPV I, LP, un'affiliata di Soleus Capital Management, per 34,0 milioni di dollari in proventi in contante. Dopo questa transazione, il Consiglio dell'azienda ha dichiarato un dividendo straordinario in contante di 4,00 dollari per azione, con una data di registrazione fissata al 24 aprile 2025 e pagamento previsto per l'8 maggio 2025.
Il valore della transazione è in linea con il valore contabile GAAP degli asset di royalty. Il CEO Jody Staggs ha sottolineato che SWK mantiene una posizione solida con un portafoglio di prestiti nel settore delle scienze della vita di circa 220 milioni di dollari che genera rendimenti in contante interessanti.
SWK Holdings (NASDAQ:SWKH) ha completado la venta previamente anunciada de sus activos de regalías a SCOF SPV I, LP, una afiliada de Soleus Capital Management, por 34,0 millones de dólares en ingresos en efectivo. Tras esta transacción, la Junta de la compañía ha declarado un dividendo en efectivo especial de 4,00 dólares por acción, con una fecha de registro del 24 de abril de 2025 y un pago programado para el 8 de mayo de 2025.
El valor de la transacción se alinea con el valor contable GAAP de los activos de regalías. El CEO Jody Staggs destacó que SWK mantiene una posición sólida con un portafolio de préstamos en ciencias de la vida de aproximadamente 220 millones de dólares que genera atractivos rendimientos en efectivo.
SWK Holdings (NASDAQ:SWKH)는 Soleus Capital Management의 자회사인 SCOF SPV I, LP에 자산 로열티의 판매를 완료했습니다. 현금 수익으로 3400만 달러에 해당합니다. 이 거래 후, 회사 이사회는 주당 4.00달러의 특별 현금 배당금을 선언했으며, 기록일은 2025년 4월 24일로, 지급일은 2025년 5월 8일로 예정되어 있습니다.
거래 가치는 로열티 자산의 GAAP 장부가와 일치합니다. CEO Jody Staggs는 SWK가 약 2억 2000만 달러의 생명 과학 대출 포트폴리오를 보유하고 있어 매력적인 현금 수익을 창출하고 있다고 강조했습니다.
SWK Holdings (NASDAQ:SWKH) a finalisé la vente précédemment annoncée de ses actifs de redevances à SCOF SPV I, LP, une filiale de Soleus Capital Management, pour 34,0 millions de dollars en produits en espèces. Suite à cette transaction, le Conseil de l'entreprise a déclaré un dividende exceptionnel en espèces de 4,00 dollars par action, avec une date d'enregistrement fixée au 24 avril 2025 et un paiement prévu pour le 8 mai 2025.
La valeur de la transaction est en accord avec la valeur comptable GAAP des actifs de redevances. Le PDG Jody Staggs a souligné que SWK maintient une position solide avec un portefeuille de prêts en sciences de la vie d'environ 220 millions de dollars générant des rendements en espèces attrayants.
SWK Holdings (NASDAQ:SWKH) hat den zuvor angekündigten Verkauf seiner Lizenzgebühren-Assets an SCOF SPV I, LP, eine Tochtergesellschaft von Soleus Capital Management, für 34,0 Millionen Dollar in Barerlösen abgeschlossen. Nach dieser Transaktion hat der Vorstand des Unternehmens eine besondere Bardividende von 4,00 Dollar pro Aktie erklärt, mit einem Stichtag am 24. April 2025 und einer Zahlung, die für den 8. Mai 2025 geplant ist.
Der Transaktionswert steht im Einklang mit dem GAAP-Buchwert der Lizenzgebühren-Assets. CEO Jody Staggs betonte, dass SWK eine starke Position mit einem Portfolio von leistungsfähigen Lebenswissenschaftskrediten im Wert von etwa 220 Millionen Dollar hat, das attraktive Barerträge generiert.
- Sale of royalty assets for $34.0 million cash proceeds
- Special dividend of $4.00 per share announced for shareholders
- $220 million performing life science loan portfolio generating cash yields
- Transaction value matches GAAP carrying value, indicating fair price realization
- Divestment of majority of royalty assets reduces revenue diversification
DALLAS, TX / ACCESS Newswire / April 10, 2025 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company, today announced the closing of the previously announced royalty sale to SCOF SPV I, LP, an affiliate of Soleus Capital Management, for total cash proceeds of approximately
In conjunction with the closing, SWK's Board of Directors has declared a special cash dividend of
"This transaction represents an attractive monetization of the majority of our royalty assets at valuation approximating the GAAP carrying value. In this uncertain market we are pleased to achieve this value for our shareholders. The special dividend reflects our continued commitment to deliver that value to our shareholders" said Jody Staggs, Chief Executive Officer of SWK Holdings. "We remain bullish on SWK's outlook which is anchored by an approximately
About SWK Holdings Corporation
SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. SWK provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. SWK's unique financing structures provide flexible financing solutions at an attractive cost of capital to create long-term value for all SWK stakeholders. SWK's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from
Safe Harbor for Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "look forward," "intend," "guidance," "future" or similar expressions are forward-looking statements. Because these statements reflect SWK's current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors, as more fully described under the caption "Risk Factors" and elsewhere in SWK's Form 10-K, Form 10-Q and Form 8-K filings with the Securities and Exchange Commission and as otherwise enumerated herein, could affect the Company's future financial results and could cause actual results to differ materially from those expressed in such forward-looking statements. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause the Company's actual results to differ materially from expected and historical results. You should not place undue reliance on any forward-looking statements, which speak only as of the date they are made. We assume no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
For more information, please contact:
Investor Relations and Media
Susan Xu
investorrelations@swkhold.com
778-323-0959
SOURCE: SWK Holdings Corp.
View the original press release on ACCESS Newswire
FAQ
When will SWK Holdings (SWKH) pay the $4.00 special dividend?
How much did SWK Holdings receive from the royalty asset sale?
What is the current size of SWKH's life science loan portfolio?
Who purchased SWK Holdings' royalty assets?
What was the valuation of SWKH's royalty asset sale compared to book value?
